About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Discovery Medicine and Clinical Pharmacology
›
Top Articles
Discovery Medicine and Clinical Pharmacology
12
(top 5%)
papers
553
(top 2%)
citations
11
(top 2%)
h
-index
12
(top 5%)
g
-index
13
all documents
575
doc citations
345
citing journals
24
times ranked
Top Articles
#
Title
Journal
Year
Citations
1
Effect of Activated Charcoal on Apixaban Pharmacokinetics in Healthy Subjects
American Journal of Cardiovascular Drugs
2014
133
2
Quantification of Apixaban's Therapeutic Utility in Prevention of Venous Thromboembolism: Selection of Phase III Trial Dose
Clinical Pharmacology and Therapeutics
2010
82
3
FERM domain mutations induce gain of function in JAK3 in adult T-cell leukemia/lymphoma
Blood
2011
79
4
Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women
HIV Medicine
2011
57
5
Differential effects of dosing regimen on the safety and efficacy of dasatinib: retrospective exposure–response analysis of a Phase III study
Clinical Pharmacology: Advances and Applications
2013
50
6
Compartmental Absorption Modeling and Site of Absorption Studies to Determine Feasibility of an Extended-Release Formulation of an HIV-1 Attachment Inhibitor Phosphate Ester Prodrug
Journal of Pharmaceutical Sciences
2013
47
7
Effect of Low-Dose Omeprazole (20 mg Daily) on the Pharmacokinetics of Multiple-Dose Atazanavir With Ritonavir in Healthy Subjects
Journal of Clinical Pharmacology
2011
38
8
Effects of Single Doses of Avagacestat (BMS-708163) on Cerebrospinal Fluid Aβ Levels in Healthy Young Men
Clinical Drug Investigation
2012
35
9
Pharmacokinetics and safety of twice-daily atazanavir 300 mg and raltegravir 400 mg in healthy individuals
Antiviral Therapy
2010
28
10
Targeting Renal Glucose Reabsorption for the Treatment of Type 2 Diabetes Mellitus Using the SGLT2 Inhibitor Dapagliflozin
Postgraduate Medicine
2012
12
11
Evaluation of safety and tolerability, pharmacokinetics, and pharmacodynamics of BMS-820836 in healthy subjects: a placebo-controlled, ascending single-dose study
Psychopharmacology
2014
11
12
Performance of Cpred/Cobs concentration ratios as a metric reflecting adherence to antidepressant drug therapy
Neuropsychiatric Disease and Treatment
2011
3
13
Molecular Pathology and Molecular Therapy
Neuropsychiatric Disease and Treatment
0
0
site/software ©
exaly
; All materials licenced under
CC by-SA
.